Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Morgan DG, Routtenberg A. The incorporation of intrastriatally injected [3H]fucose into electrophoretically separated synaptosomal glycoproteins. II. The influence of passive avoidance training. Brain Res. 1979 Dec 28;179(2):343-54. doi: 10.1016/0006-8993(79)90449-9. PubMed PMID: 509242.
Morgan DG, Routtenberg A. Incorporation of intrastriatally injected[3H]fucose into electrophoretically separated synaptosomal glycoproteins. I. Turnover and molecular weight estimations. Brain Res. 1979 Dec 28;179(2):329-41. doi: 10.1016/0006-8993(79)90448-7. PubMed PMID: 509241.
Morgan DG, Routtenberg A. Evidence that a 41,000 dalton brain phosphoprotein is pyruvate dehydrogenase. Biochem Biophys Res Commun. 1980 Jul 31;95(2):569-76. doi: 10.1016/0006-291x(80)90822-0. PubMed PMID: 7417275.
Mitrius JC, Morgan DG, Routtenberg A. In vivo phosphorylation following [32P]orthophosphate injection into neostriatum or hippocampus: selective and rapid labeling of electrophoretically separated brain proteins. Brain Res. 1981 May 11;212(1):67-81. doi: 10.1016/0006-8993(81)90033-0. PubMed PMID: 7225866.
Routtenberg A, Morgan DG, Conway RG, Schmidt MJ, Ghetti B. Human brain protein phosphorylation in vitro: cyclic AMP stimulation of electrophoretically-separated substrates. Brain Res. 1981 Oct 19;222(2):323-33. doi: 10.1016/0006-8993(81)91036-2. PubMed PMID: 6269696.
Morgan DG, Routtenberg A. Brain pyruvate dehydrogenase: phosphorylation and enzyme activity altered by a training experience. Science. 1981 Oct 23;214(4519):470-1. doi: 10.1126/science.7291989. PubMed PMID: 7291989.
Morgan DG, Routtenberg A. Brain pyruvate dehydrogenase activity: regulation by phosphorylation-dephosphorylation. Brain Res. 1982 Nov 18;251(2):391-4. doi: 10.1016/0006-8993(82)90761-2. PubMed PMID: 7139337.
Joseph JA, Bartus RT, Clody D, Morgan D, Finch C, Beer B, Sesack S. Psychomotor performance in the senescent rodent: reduction of deficits via striatal dopamine receptor up-regulation. Neurobiol Aging. 1983 Winter;4(4):313-9. doi: 10.1016/0197-4580(83)90008-8. PubMed PMID: 6687001.
Morgan DG, Sinha YN, Finch CE. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol. Neuroendocrinology. 1984 May;38(5):407-10. doi: 10.1159/000123926. PubMed PMID: 6728123.
Morgan DG, Marcusson JO, Finch CE. Contamination of serotonin-2 binding sites by an alpha-1 adrenergic component in assays with (3H)spiperone. Life Sci. 1984 Jun 18;34(25):2507-14. doi: 10.1016/0024-3205(84)90288-1. PubMed PMID: 6328167.
Marcusson JO, Morgan DG, Winblad B, Finch CE. Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age. Brain Res. 1984 Oct 8;311(1):51-6. doi: 10.1016/0006-8993(84)91397-0. PubMed PMID: 6488044.
Morgan DG, Mobbs CV, Anderson CP, Sinha YN, Finch CE. Hyperprolactinemia fails to increase striatal dopamine receptors in male and female C57BL/6J mice. Eur J Pharmacol. 1984 Dec 15;107(1):101-4. doi: 10.1016/0014-2999(84)90097-9. PubMed PMID: 6526068.
Rogers J, Shoemaker WJ, Morgan DG, Finch CE. Senescent change in tissue weight and immunoreactive beta-endorphin, enkephalin, and vasopressin in eight regions of C57BL/6J mouse brain and pituitary. Neurobiol Aging. 1985 Spring;6(1):1-9. doi: 10.1016/0197-4580(85)90064-8. PubMed PMID: 3158833.
Johnson SA, Morgan DG, Finch CE. Extensive postmortem stability of RNA from rat and human brain. J Neurosci Res. 1986;16(1):267-80. doi: 10.1002/jnr.490160123. PubMed PMID: 2427740.
Morgan DG, Finch CE. [3H]Fluphenazine binding to brain membranes: simultaneous measurement of D-1 and D-2 receptor sites. J Neurochem. 1986 May;46(5):1623-31. doi: 10.1111/j.1471-4159.1986.tb01785.x. PubMed PMID: 2937884.
May PC, Morgan DG, Finch CE. Regional serotonin receptor studies: chronic methysergide treatment induces a selective and dose-dependent decrease in serotonin-2 receptors in mouse cerebral cortex. Life Sci. 1986 May 12;38(19):1741-7. doi: 10.1016/0024-3205(86)90124-4. PubMed PMID: 3702603.
May PC, Osterburg HH, Mandel RJ, Morgan DG, Randall PK, Finch CE. Alteration of calmodulin distribution does not accompany dopaminergic supersensitization of the mouse striatum. J Neurosci Res. 1987;17(3):247-50. doi: 10.1002/jnr.490170307. PubMed PMID: 3037094.
Morgan DG, Randall JS, Telford NA, Gordon MN, Sinha YN, Finch CE, Randall PK. Genotypic influences on pituitary responsiveness to haloperidol in mice. Psychoneuroendocrinology. 1987;12(3):211-8. doi: 10.1016/0306-4530(87)90006-0. PubMed PMID: 3615750.
Morgan DG, May PC, Finch CE. Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease. J Am Geriatr Soc. 1987 Apr;35(4):334-45. doi: 10.1111/j.1532-5415.1987.tb04641.x. Review. PubMed PMID: 3549845.
Osterburg HH, Telford NA, Morgan DG, Cohen-Becker I, Wise PM, Finch CE. Hypothalamic monoamines and their catabolites in relation to the estradiol-induced luteinizing hormone surge. Brain Res. 1987 Apr 14;409(1):31-40. doi: 10.1016/0006-8993(87)90738-4. PubMed PMID: 3580869.
Morgan DG, Marcusson JO, Nyberg P, Wester P, Winblad B, Gordon MN, Finch CE. Divergent changes in D-1 and D-2 dopamine binding sites in human brain during aging. Neurobiol Aging. 1987 May-Jun;8(3):195-201. doi: 10.1016/0197-4580(87)90002-9. PubMed PMID: 3600950.
Morgan DG, Finch CE. Dopaminergic changes in the basal ganglia. A generalized phenomenon of aging in mammals. Ann N Y Acad Sci. 1988;515:145-60. doi: 10.1111/j.1749-6632.1988.tb32978.x. PubMed PMID: 3364883.
Morgan DG, Gordon MN. New approaches to the study of central nervous system function. Immune-nervous system interactions and cell culture. Neurobiol Aging. 1988 Sep-Dec;9(5-6):763-5. doi: 10.1016/s0197-4580(88)80144-1. PubMed PMID: 3211271.
Pasinetti GM, Morgan DG, Johnson SA, Lerner SP, Myers MA, Poirier J, Finch CE. Combined in situ hybridization and immunocytochemistry in the assay of pharmacological effects on tyrosine hydroxylase mRNA concentration. Pharmacol Res. 1989 May-Jun;21(3):299-311. doi: 10.1016/s1043-6618(89)80008-8. PubMed PMID: 2568627.
Pasinetti GM, Lerner SP, Johnson SA, Morgan DG, Telford NA, Finch CE. Chronic lesions differentially decrease tyrosine hydroxylase messenger RNA in dopaminergic neurons of the substantia nigra. Brain Res Mol Brain Res. 1989 May;5(3):203-9. doi: 10.1016/0169-328x(89)90036-3. PubMed PMID: 2566883.
Finch CE, Morgan DG. RNA and protein metabolism in the aging brain. Annu Rev Neurosci. 1990;13:75-88. doi: 10.1146/ Review. PubMed PMID: 1691607.
Goss JR, Finch CE, Morgan DG. GFAP RNA increases during a wasting state in old mice. Exp Neurol. 1990 Jun;108(3):266-8. doi: 10.1016/0014-4886(90)90133-d. PubMed PMID: 1693579.
Pasinetti GM, Morgan DG, Johnson SA, Millar SL, Finch CE. Tyrosine hydroxylase mRNA concentration in midbrain dopaminergic neurons is differentially regulated by reserpine. J Neurochem. 1990 Nov;55(5):1793-9. doi: 10.1111/j.1471-4159.1990.tb04970.x. PubMed PMID: 1976760.
Goss JR, Finch CE, Morgan DG. Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain. Neurobiol Aging. 1991 Mar-Apr;12(2):165-70. doi: 10.1016/0197-4580(91)90056-p. PubMed PMID: 2052130.
Pasinetti GM, Morgan DG, Finch CE. Disappearance of GAD-mRNA and tyrosine hydroxylase in substantia nigra following striatal ibotenic acid lesions: evidence for transneuronal regression. Exp Neurol. 1991 May;112(2):131-9. doi: 10.1016/0014-4886(91)90063-i. PubMed PMID: 1674692.
Pasinetti GM, Osterburg HH, Kelly AB, Kohama S, Morgan DG, Reinhard JF Jr, Stellwagen RH, Finch CE. Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: a model for neuron aging. Brain Res Mol Brain Res. 1992 Mar;13(1-2):63-73. doi: 10.1016/0169-328x(92)90045-d. PubMed PMID: 1374506.
Pasinetti GM, Johnson SA, Rozovsky I, Lampert-Etchells M, Morgan DG, Gordon MN, Morgan TE, Willoughby D, Finch CE. Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp Neurol. 1992 Nov;118(2):117-25. doi: 10.1016/0014-4886(92)90028-o. PubMed PMID: 1426121.
Randerath K, Putman KL, Osterburg HH, Johnson SA, Morgan DG, Finch CE. Age-dependent increases of DNA adducts (I-compounds) in human and rat brain DNA. Mutat Res. 1993 Jan;295(1):11-8. doi: 10.1016/0921-8734(93)90007-p. PubMed PMID: 7677925.
Pasinetti GM, Cheng HW, Morgan DG, Lampert-Etchells M, McNeill TH, Finch CE. Astrocytic messenger RNA responses to striatal deafferentation in male rat. Neuroscience. 1993 Mar;53(1):199-211. doi: 10.1016/0306-4522(93)90298-t. PubMed PMID: 8469307.
Yu ZJ, Morgan DG, Wecker L. Distribution of three nicotinic receptor alpha 4 mRNA transcripts in rat brain: selective regulation by nicotine administration. J Neurochem. 1996 Mar;66(3):1326-9. doi: 10.1046/j.1471-4159.1996.66031326.x. PubMed PMID: 8769902.
Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature. 1996 Oct 24;383(6602):710-3. doi: 10.1038/383710a0. PubMed PMID: 8878479.
Benkovic SA, McGowan EM, Rothwell NJ, Hutton M, Morgan DG, Gordon MN. Regional and cellular localization of presenilin-2 RNA in rat and human brain. Exp Neurol. 1997 Jun;145(2 Pt 1):555-64. doi: 10.1006/exnr.1997.6487. PubMed PMID: 9217091.
Gordon MN, Schreier WA, Ou X, Holcomb LA, Morgan DG. Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat. J Comp Neurol. 1997 Nov 10;388(1):106-19. PubMed PMID: 9364241.
Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med. 1998 Jan;4(1):97-100. doi: 10.1038/nm0198-097. PubMed PMID: 9427614.
Morgan D, Holcomb L, Saad I, Gordon M, Mahin Maines. Impaired spatial navigation learning in transgenic mice over-expressing heme oxygenase-1. Brain Res. 1998 Oct 12;808(1):110-2. doi: 10.1016/s0006-8993(98)00803-8. PubMed PMID: 9795173.
Pennypacker KR, Hernandez H, Benkovic S, Morgan DG, Willing AE, Sanberg PR. Induction of presenilins in the rat brain after middle cerebral arterial occlusion. Brain Res Bull. 1999 Mar 15;48(5):539-43. doi: 10.1016/s0361-9230(99)00031-3. PubMed PMID: 10372515.
Holcomb LA, Gordon MN, Jantzen P, Hsiao K, Duff K, Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet. 1999 May;29(3):177-85. doi: 10.1023/a:1021691918517. PubMed PMID: 10547924.
Gordon MN, Muller CD, Sherman KA, Morgan DG, Azzaro AJ, Wecker L. Oral versus transdermal selegiline: antidepressant-like activity in rats. Pharmacol Biochem Behav. 1999 Jul;63(3):501-6. doi: 10.1016/s0091-3057(99)00016-7. PubMed PMID: 10418793.
Wright KL, Morgan DG, Yu X, Goss JR, Salbaum JM, Duff K, Gordon MN. Mice transgenic for a human amyloid precursor protein promoter-lacZ reporter construct. J Mol Neurosci. 1999 Aug-Oct;13(1-2):111-20. doi: 10.1385/jmn:13:1-2:111. PubMed PMID: 10691298.
Holcomb LA, Gordon MN, Benkovic SA, Morgan DG. A beta and perlecan in rat brain: glial activation, gradual clearance and limited neurotoxicity. Mech Ageing Dev. 2000 Jan 3;112(2):135-52. doi: 10.1016/s0047-6374(99)00086-x. PubMed PMID: 10690926.
Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 2000 Dec 21-28;408(6815):982-5. doi: 10.1038/35050116. PubMed PMID: 11140686.
Morgan D. The intersection of Alzheimer's disease and typical aging. Neurobiol Aging. 2001 Jan-Feb;22(1):159-60; discussion 161-3. doi: 10.1016/s0197-4580(00)00208-6. PubMed PMID: 11164292.
Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, Hope CE, Diamond DM. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 2001 Feb 9;891(1-2):42-53. doi: 10.1016/s0006-8993(00)03186-3. PubMed PMID: 11164808.
Nilsson LN, Bales KR, DiCarlo G, Gordon MN, Morgan D, Paul SM, Potter H. Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease. J Neurosci. 2001 Mar 1;21(5):1444-51. doi: 10.1523/JNEUROSCI.21-05-01444.2001. PubMed PMID: 11222634; PubMed Central PMCID: PMC6762932.
What would you like to do?